FUJIFILM Holdings Co. (OTCMKTS:FUJIY) Sees Large Increase in Short Interest

FUJIFILM Holdings Co. (OTCMKTS:FUJIY) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 4,300 shares, a growth of 26.5% from the November 15th total of 3,400 shares. Based on an average daily trading volume, of 423,400 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded shares of FUJIFILM from a “hold” rating to a “buy” rating in a research report on Tuesday, August 20th.

FUJIFILM Stock Down 1.7 %

Shares of OTCMKTS:FUJIY traded down $0.20 during trading on Friday, hitting $11.11. 122,780 shares of the company’s stock traded hands, compared to its average volume of 100,548. The company has a 50-day moving average price of $11.57 and a 200-day moving average price of $11.95. FUJIFILM has a 52 week low of $9.51 and a 52 week high of $13.88. The company has a current ratio of 1.35, a quick ratio of 0.85 and a debt-to-equity ratio of 0.11. The company has a market cap of $27.64 billion, a price-to-earnings ratio of 15.97, a price-to-earnings-growth ratio of 2.42 and a beta of 0.40.

FUJIFILM (OTCMKTS:FUJIY) last released its quarterly earnings results on Thursday, November 7th. The technology company reported $0.55 earnings per share for the quarter. FUJIFILM had a net margin of 7.78% and a return on equity of 7.54%. The company had revenue of $5.15 billion during the quarter. As a group, research analysts forecast that FUJIFILM will post 0.68 EPS for the current fiscal year.

FUJIFILM Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.